Table 1 Characteristics of CD patients included in the study.
From: Stenosing Crohn’s disease patients display gut autophagy/oxidative stress imbalance
Characteristics | Control group (n = 11) | Inflammatory CD (n = 15) | Stenosing CD (n = 10) | Total CD (n = 25) |
|---|---|---|---|---|
Age (mean years ± SD) | 69 ± 9** | 44 ± 17 | 51 ± 15 | 47 ± 16 |
Gender (F/M) | 4/7 | 10/5 | 4/6 | 14/11 |
Disease duration (mean years ± SD) | n.a | 6.6 ± 7.6 | 15.5 ± 8.7* | 10.2 ± 9.1 |
Location | ||||
L1 | n.a | 5 (33%) | 7 (70%) | 12 (46%) |
L2 | n.a | 7 (47%) | 1 (10%) | 8 (31%) |
L3 | n.a | 3 (20%) | 2 (20%) | 6 (23%) |
Therapy | ||||
Mesalamine | n.a | 10 (67%) | 6 (60%) | 16 (64%) |
Prednisone < 30 mg/die | n.a | 4 (27%) | – | 4 (16%) |
None | n.a | 1 (6%) | 4 (40%) | 5 (20%) |
